JCN Newswire Read More Eisai Presents Results of Post Hoc Analysis of Eribulin Mesylate (HALAVEN) at the European Society for Medical Oncology (ESMO) Congress 2022 ruth 12 9 月 2 minutes TOKYO, Sep 12, 2022 – (J […]
